TCM
CALT

Tang Capital Management’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Tang Capital Management’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$2.48M – 57
2021
Q4 		$2.48M Buy
+100,000
New +$2.01M 0.5% 25

Other funds holding CALT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tang Capital Management's CALT Position: Q1 2022 in Review

Tang Capital Management sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q1 2022, closing a stake of 100,000 shares — an estimated $2.48M sold.

Tang Capital Management first reported a position in CALT in Q4 2021 and held it in 1 quarter. The position peaked at $2.48M in Q4 2021. 17 funds tracked by Wall St. Rank hold CALT as of Q1 2022.

  • Tang Capital Management reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Tang Capital Management sold 100,000 Calliditas Therapeutics AB American Depositary Shares shares in Q1 2022, an estimated $2.48M.
  • Tang Capital Management first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Tang Capital Management's Calliditas Therapeutics AB American Depositary Shares position peaked at $2.48M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q1 2022.

Based on Tang Capital Management's 13F filing for Q1 2022, filed 16 May 2022.